Page 102 - 南京医科大学学报自然科学版
P. 102
第43卷第4期
·540 · 南 京 医 科 大 学 学 报 2023年4月
显著正相关性,因此对于 NLR、MLR、SLL 增高的 [7] MIRILI C,GUNEY I B,PAYDAS S,et al. Prognostic sig⁃
SCLC患者而言,可通过全身PET/CT检查进行分期, nificance of neutrophil/lymphocyte ratio(NLR)and corre⁃
从而调整后续的治疗方案。 lation with PET ⁃ CT metabolic parameters in small cell
本研究存在一定局限性。首先,本研究为回顾 lung cancer(SCLC)[J]. Int J Clin Oncol,2019,24(2):
性研究,因此对于炎症相关肺病如慢性阻塞性肺疾 168-178
[8] ZHAO L,LI T,YANG Y,et al. Clinical value of neutro⁃
病(chronic obstructive pulmonary disease,COPD)、阻
phil⁃to⁃lymphocyte ratio as a predictor of prognosis of Ret⁃
塞性肺炎、间质性肺炎和其他炎性病变均不能进行
roNectin((R))⁃ activated cytokine ⁃ induced killer cell
严格控制,此外吸烟也可引起系统性炎症,但本研
therapy in advanced non⁃small⁃cell lung cancer[J]. Im⁃
究中不吸烟与吸烟患者之间的 NLR、PLR 差异无统 munotherapy,2019,11(4):273-282
计学意义;其次,本研究中广泛期SCLC患者样本量 [9] LI X,DAI D,CHEN B,et al. The value of neutrophil⁃to⁃
相对较少,可能会引起整体数据偏倚,今后应进一 lymphocyte ratio for response and prognostic effect of neo⁃
步开展前瞻性研究;最后,本研究只选取炎症细胞 adjuvant chemotherapy in solid tumors:a systematic re⁃
作为研究,而近年来越来越多炎症指标被证实参与 view and meta⁃analysis[J]. J Cancer,2018,9(5):861-
肿瘤发生发展等过程,如白细胞介素⁃6(interleukin⁃ 6, 871
IL⁃6)、C 反应蛋白(C⁃reactive protein,CRP)、脂多糖 [10] BOISSIER R,CAMPAGNA J,BRANGER N,et al. The
结合蛋白等 [23-24] ,对于其他炎症指标与肿瘤 F⁃FDG prognostic value of the neutrophil⁃lymphocyte ratio in re⁃
18
nal oncology:a review[J]. Urol Oncol,2017,35(4):
代谢之间相关性需要更多基础及临床研究证实。
135-141
综上所述,SCLC 患者基线 NLR、PLR、MLR、SII 与
[11] KASMANN L,BOLM L,SCHILD S E,et al. Neutrophil⁃
PET/CT 代谢参数(MTV 和 TLG)之间存在正相关
to ⁃ lymphocyte ratio predicts outcome in limited disease
性。基线 NLR、MLR、SII 不仅反映全身系统的炎 small⁃cell lung cancer[J]. Lung,2017,195(2):217-224
症,还可能反映肿瘤病灶以 F⁃FDG 活性为代表的 [12] WANG X,TENG F,KONG L,et al. Pretreatment neutro⁃
18
炎症情况。且对于NLR、MLR、SII增高的SCLC患者 phil⁃to⁃lymphocyte ratio as a survival predictor for small⁃
而言,有必要通过 PET/CT 检查进行分期,从而调整 cell lung cancer[J]. Onco Targets Ther,2016,9:5761-
后续的治疗方案。 5770
[13] QIAN S,GOLUBNITSCHAJA O,ZHAN X. Chronic in⁃
[参考文献]
flammation:key player and biomarker⁃set to predict and
[1] SIEGEL R L,MILLER K D,FUCHS H E,et al. Cancer prevent cancer development and progression based on in⁃
statistics,2021[J]. CA Cancer J Clin,2021,71(1):7-33 dividualized patient profiles[J]. EPMA J,2019,10(4):
[2] RUDIN C M,BRAMBILLA E,FAIVRE⁃FINN C,et al. 365-381
Small⁃cell lung cancer[J]. Nat Rev Dis Primers,2021,7 [14] 罗后宙,陈国强. 外周血中性粒细胞/淋巴细胞比值和
(1):3 血小板/淋巴细胞比值预测前列腺癌去势治疗后的病
18
[3] 高珂梦,李天女,丁重阳,等. 肺小细胞癌 F⁃FDG PET 情进展[J]. 南京医科大学学报(自然科学版),2022,42
代谢参数与相关代谢指标的关系[J]. 南京医科大学学 (9):1265-1270
报(自然科学版),2020,40(12):1855-1859 [15] JEONG E,HYUN S H,MOON S H,et al. Relation
[4] ARAZ M,SOYDAL C,OZKAN E,et al. Prognostic value between tumor FDG uptake and hematologic prognostic
18
of metabolic parameters on baseline F⁃FDG PET/CT in indicators in stage I lung cancer patients following curative
small cell lung cancer[J]. Q J Nucl Med Mol Imaging, resection[J]. Medicine,2017,96(5):e5935
2022,66(1):61-66 [16] WANG Y,ZHAO N,WU Z,et al. New insight on the cor⁃
[5] ALTORKI N K,MARKOWITZ G J,GAO D,et al. The relation of metabolic status on F⁃FDG PET/CT with im⁃
18
lung microenvironment:an important regulator of tumour mune marker expression in patients with non⁃small cell
growth and metastasis[J]. Nat Rev Cancer,2019,19(1): lung cancer[J]. Eur J Nucl Med Mol Imaging,2020,47
9-31 (5):1127-1136
[6] ISHIBASHI Y,TSUJIMOTO H,YAGUCHI Y,et al. Prog⁃ [17] FUJII T,TOKUDA S,NAKAZAWA Y,et al. Relationship
nostic significance of systemic inflammatory markers in between FDG uptake and the platelet/lymphocyte ratio in
esophageal cancer:Systematic review and meta⁃analysis patients with breast invasive ductal cancer[J]. In Vivo,
[J]. Ann Gastroenterol Surg,2020,4(1):56-63 2020,34(3):1365-1369